FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Woods

Research Profile

Living Beings

Concepts & Ideas

Drug Dose Response Relationship

Chemicals & Drugs

Procedures

Activities & Behaviors

Animal Behavior

Physiology

Co-author Network

Publications

TOP 3
Mikhail N Koffarnus; James H Woods
Individual differences in discount rate are associated with demand for self-administered cocaine, but not sucrose.
Humphrey A Moynihan; Lauren C S Purington; Mark P Thomas; John R Traynor; James H Woods; Mario D Aceto; Jillian Broadbear; Ian Derrick; Benjamin M Greedy; Louis S Harris; Stephen M Husbands; John W Lewis
Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects.
Mikhail N Koffarnus; Kenner C Rice; Jianyong Chen; Gregory Collins; James H Woods; Gail Winger
Self-administration of agonists selective for dopamine D2, D3, and D4 receptors by rhesus monkeys.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Woods (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mikhail N Koffarnus; James H Woods
Individual differences in discount rate are associated with demand for self-administered cocaine, but not sucrose.
Addiction biology 2013;18(1):8-18.
2012: Humphrey A Moynihan; Lauren C S Purington; Mark P Thomas; John R Traynor; James H Woods; Mario D Aceto; Jillian Broadbear; Ian Derrick; Benjamin M Greedy; Louis S Harris; Stephen M Husbands; John W Lewis
Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects.
Journal of medicinal chemistry 2012;55(22):9868-74.
2012: Mikhail N Koffarnus; Kenner C Rice; Jianyong Chen; Gregory Collins; James H Woods; Gail Winger
Self-administration of agonists selective for dopamine D2, D3, and D4 receptors by rhesus monkeys.
Behavioural pharmacology 2012;23(4):331-8.
2012: Gregory Collins; Remy L Brim; Nicholas W Lukacs; Diwahar Narasimhan; Kathleen R Noon; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 2012;342(1):205-13.
2012: Tien-Yi Lee; Yoon Shin Park; Roger K Sunahara; James H Woods; George A Garcia; Victor C Yang
Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination.
Molecular pharmaceutics 2012;9(5):1361-73.
2012: Gregory Collins; Alyssa R Cunningham; Mei-Chuan Ko; Diwahar Narasimhan; Joseph Nichols; Roger K Sunahara; Matthew E Zaks; James H Woods
Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012;37(5):1092-103.
2012: Diwahar Narasimhan; James H Woods; Roger K Sunahara
Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction.
Future medicinal chemistry 2012;4(2):137-50.
2012: Remy L Brim; Diwa Narasimhan; Gregory T Collins; James H Woods; Joseph Nichols; Kathleen R Noon; Mei-Chuan Ko; Aron Stein; Roger K Sunahara
The fate of bacterial cocaine esterase (CocE): an in vivo study of CocE-mediated cocaine hydrolysis, CocE pharmacokinetics, and CocE elimination.
The Journal of pharmacology and experimental therapeutics 2012;340(1):83-95.
2012: Gregory T Collins; Amy H Newman; Alyssa R Cunningham; Jianyong Chen; Shaomeng Wang; James H Woods
Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats.
Psychopharmacology 2012;219(1):123-35.
2011: Remy L Brim; Diwahar Narasimhan; Joseph Nichols; Kathleen R Noon; James H Woods; Roger K Sunahara
Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs.
Drug and alcohol dependence 2011;119(3):224-8.
2011: Diwahar Narasimhan; Joseph Nichols; John J G Tesmer; James H Woods; Jimmy Chan; Gregory Collins; Elin Edwald; Mei-Chuan Ko; Mark R Nance; Roger K Sunahara
Subunit stabilization and polyethylene glycolation of cocaine esterase improves in vivo residence time.
Molecular pharmacology 2011;80(6):1056-65.
2011: Remy L Brim; Gregory Collins; Diwahar Narasimhan; Joseph Nichols; Kathleen R Noon; Roger K Sunahara; James H Woods
The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry.
Molecular pharmacology 2011;80(6):1119-27.
2011: Gregory Collins; Alyssa R Cunningham; Mei-Chuan Ko; Diwahar Narasimhan; Joseph Nichols; Carley St Clair; Roger K Sunahara; Matthew E Zaks; James H Woods
Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats.
Drug and alcohol dependence 2011;118(2-3):158-65.
2011: Corina Jimenez-Gomez; Andrew Osentoski; James H Woods
Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety.
Behavioural pharmacology 2011;22(7):711-3.
2011: Emily Jutkiewicz; Adam D Kynaston; Kenner C Rice; Emily A Brooks; James H Woods
Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
The Journal of pharmacology and experimental therapeutics 2011;339(1):194-202.
2011: Mikhail N Koffarnus; Amy H Newman; Kenner C Rice; Peter Grundt; James H Woods
Effects of selective dopaminergic compounds on a delay-discounting task.
Behavioural pharmacology 2011;22(4):300-11.
2011: Gregory Collins; Yen Nhu-Thi Truong; Beth Levant; Jianyong Chen; Shaomeng Wang; James H Woods
Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity.
Psychopharmacology 2011;215(4):609-20.
2011: Gregory T Collins; Kathy A Carey; Diwahar Narasimhan; Joseph Nichols; Aaron A Berlin; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2011;36(5):1047-59.
2011: Corina Jimenez-Gomez; Reginald L Dean; Daniel R Deaver; Gail Winger; James H Woods
Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys.
Behavioural pharmacology 2011;22(1):87-90.
2011: Liu Xue; Mei-Chuan Ko; Min Tong; Wenchao Yang; Shurong Hou; Lei Fang; Junjun Liu; Fang Zheng; James H Woods; Hsin-Hsiung Tai; Chang-Guo Zhan
Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine.
Molecular pharmacology 2011;79(2):290-7.
2011: Christopher A Podlesnik; Mei-Chuan Ko; Gail Winger; Jürgen Wichmann; Eric P Prinssen; James H Woods
The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys.
Psychopharmacology 2011;213(1):53-60.
2010: William E Fantegrossi; J Simoneau; M S Cohen; S M Zimmerman; C M Henson; K C Rice; James H Woods
Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
The Journal of pharmacology and experimental therapeutics 2010;335(3):728-34.
2010: Rama Pichika; Douglas M Jewett; Philip S Sherman; John R Traynor; Stephen M Husbands; James H Woods; Michael R Kilbourn
Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists.
Nuclear medicine and biology 2010;37(8):989-96.
2010: Ziva D Cooper; Yong-Gong Shi; James H Woods
Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats.
Psychopharmacology 2010;212(3):369-78.
2010: Diwahar Narasimhan; Mark R Nance; Daquan Gao; Mei-Chuan Ko; Joanne Macdonald; Patricia Tamburi; Dan Yoon; Donald M Landry; James H Woods; Chang-Guo Zhan; John J G Tesmer; Roger K Sunahara
Structural analysis of thermostabilizing mutations of cocaine esterase.
Protein engineering, design & selection : PEDS 2010;23(7):537-47.
2010: Su-Min Li; Gregory Collins; Noel M Paul; Peter Grundt; Amy Hauck Newman; Ming Xu; David K Grandy; James H Woods; Jonathan L Katz
Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats.
Behavioural pharmacology 2010;21(3):171-81.
2010: Remy L Brim; Mark R Nance; Daniel W Youngstrom; Diwahar Narasimhan; Chang-Guo Zhan; John J G Tesmer; Roger K Sunahara; James H Woods
A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse.
Molecular pharmacology 2010;77(4):593-600.
2010: Jun-Beom Park; Young Min Kwon; Tien-Yi Lee; Remy Brim; Mei-Chuan Ko; Roger K Sunahara; James H Woods; Victor C Yang
PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity.
Journal of controlled release : official journal of the Controlled Release Society 2010;142(2):174-9.
2010: Christopher A Podlesnik; Corina Jimenez-Gomez; James H Woods
A choice procedure to assess the aversive effects of drugs in rodents.
Journal of the experimental analysis of behavior 2010;93(2):203-23.
2010: Susan K Wood; Diwahar Narasimhan; Ziva D Cooper; Roger K Sunahara; James H Woods
Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats.
Drug and alcohol dependence 2010;106(2-3):219-29.
2009: Nick P R Nieland; David Rennison; Jillian H Broadbear; Lauren Purington; James H Woods; John R Traynor; John W Lewis; Stephen M Husbands
14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. Further examples of pseudoirreversible mu opioid receptor antagonists.
Journal of medicinal chemistry 2009;52(21):6926-30.
2009: Gregory Collins; Remy L Brim; Diwahar Narasimhan; Mei-Chuan Ko; Roger K Sunahara; Chang-Guo Zhan; James H Woods
Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats.
The Journal of pharmacology and experimental therapeutics 2009;331(2):445-55.
2009: Gregory Collins; James H Woods
Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats.
Behavioural pharmacology 2009;20(5-6):492-504.
2009: Emily Jutkiewicz; Michelle G Baladi; Ziva D Cooper; Diwahar Narasimhan; Roger K Sunahara; James H Woods
A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality.
Annals of emergency medicine 2009;54(3):409-20.
2009: Mei-Chuan Ko; James H Woods; William E Fantegrossi; Chad M Galuska; Jürgen Wichmann; Eric P Prinssen
Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(9):2088-96.
2009: Mei-Chuan Ko; Diwahar Narasimhan; Aaron A Berlin; Nicholas W Lukacs; Roger K Sunahara; James H Woods
Effects of cocaine esterase following its repeated administration with cocaine in mice.
Drug and alcohol dependence 2009;101(3):202-9.
2009: Gregory Collins; Andrew Truccone; Faiza Haji-Abdi; Amy Hauck Newman; Peter Grundt; Kenner C Rice; Stephen M Husbands; Benjamin M Greedy; Cecile Enguehard-Gueiffier; Alain Gueiffier; Jianyong Chen; Shaomeng Wang; Jonathan L Katz; David K Grandy; Roger K Sunahara; James H Woods
Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice.
The Journal of pharmacology and experimental therapeutics 2009;329(1):210-7.
2009: Mikhail N Koffarnus; Benjamin Greedy; Stephen M Husbands; Peter Grundt; Amy Hauck Newman; James H Woods
The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
Psychopharmacology 2009;203(2):317-27.
2009: H Moynihan; Andrew R Jales; B M Greedy; David Rennison; Jillian H Broadbear; L Purington; John R Traynor; James H Woods; John W Lewis; Stephen M Husbands
14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity.
Journal of medicinal chemistry 2009;52(6):1553-7.
2009: Daquan Gao; Diwahar L Narasimhan; Joanne Macdonald; Remy Brim; Mei-Chuan Ko; Donald W Landry; James H Woods; Roger K Sunahara; Chang-Guo Zhan
Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity.
Molecular pharmacology 2009;75(2):318-23.
2008: Gregory Collins; James H Woods
Narrowing in on compulsions: dopamine receptor functions.
Experimental and clinical psychopharmacology 2008;16(6):498-502.
2008: Jianyong Chen; Gregory Collins; Zhang Jian; Chao-Yie Yang; Beth Levant; James H Woods; Shaomeng Wang
Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile.
Journal of medicinal chemistry 2008;51(19):5905-8.
2008: Fang Zheng; Wenchao Yang; Mei-Chuan Ko; Junjun Liu; Hoon Cho; Daquan Gao; Min Tong; Hsin-Hsiung Tai; James H Woods; Chang-Guo Zhan
Most efficient cocaine hydrolase designed by virtual screening of transition states.
Journal of the American Chemical Society 2008;130(36):12148-55.
2008: Ziva D Cooper; Yen Nhu-Thi Truong; Yong-Gong Shi; James H Woods
Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat.
The Journal of pharmacology and experimental therapeutics 2008;326(3):920-9.
2008: Hong Xie; James H Woods; John R Traynor; Mei-Chuan Ko
The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
Anesthesia and analgesia 2008;106(6):1873-81.
2008: John E Pascoe; KL Williams; Partha Mukhopadhyay; Kenner C Rice; James H Woods; Mei-Chuan Ko
Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys.
Psychoneuroendocrinology 2008;33(4):478-86.
2008: Gregory Collins; Diane M Calinski; Amy Hauck Newman; Peter Grundt; James H Woods
Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects.
The Journal of pharmacology and experimental therapeutics 2008;325(2):691-7.
2008: Mikhail N Koffarnus; James H Woods
Quantification of drug choice with the generalized matching law in rhesus monkeys.
Journal of the experimental analysis of behavior 2008;89(2):209-24.
2008: Emily Jutkiewicz; Michelle G Baladi; John E Folk; Kenner C Rice; James H Woods
The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
The Journal of pharmacology and experimental therapeutics 2008;324(2):714-24.
2008: William E Fantegrossi; J R Ciullo; K T Wakabayashi; Richard De La Garza; John R Traynor; James H Woods
A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse.
Neuroscience 2008;151(2):533-43.
2008: Matthew D Metcalf; Mario D Aceto; Louis S Harris; James H Woods; John R Traynor; Andrew Coop; Everette L May
The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans.
Bioorganic & medicinal chemistry 2008;16(2):869-73.
2007: Susan K Wood; James H Woods
Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances.
Expert opinion on therapeutic targets 2007;11(11):1401-13.
2007: Gregory Collins; James H Woods
Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat.
The Journal of pharmacology and experimental therapeutics 2007;323(2):599-605.
2007: Tammy Wade-Galuska; Gail Winger; James H Woods
A behavioral economic analysis of cocaine and remifentanil self-administration in rhesus monkeys.
Psychopharmacology 2007;194(4):563-72.
2007: Huina Zhang; Yong-Gong Shi; James H Woods; Stanley J Watson Jr; Mei-Chuan Ko
Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies.
European journal of pharmacology 2007;570(1-3):89-96.
2007: Kathryn K Chadman; James H Woods; Jerry A Stitzel
Chlorisondamine inhibits the nicotine-induced stimulation of c-fos in the pigeon brain for up to 2 weeks.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2007;9(9):927-36.
2007: Heeseung Lee; Norah N Naughton; James H Woods; Mei-Chuan Ko
Effects of butorphanol on morphine-induced itch and analgesia in primates.
Anesthesiology 2007;107(3):478-85.
2007: Gregory Collins; Amy Hauck Newman; Peter Grundt; Kenner C Rice; Stephen M Husbands; Cédric Chauvignac; Jianyong Chen; Shaomeng Wang; James H Woods
Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.
Psychopharmacology 2007;193(2):159-70.
2007: Chad M Galuska; Tammy Wade-Galuska; James H Woods; Gail Winger
Fixed-ratio schedules of cocaine self-administration in rhesus monkeys: joint control of responding by past and upcoming doses.
Behavioural pharmacology 2007;18(2):171-5.
2007: Mei-Chuan Ko; Luvina D Bowen; Diwahar Narasimhan; Aaron A Berlin; Nicholas W Lukacs; Roger K Sunahara; Ziva D Cooper; James H Woods
Cocaine esterase: interactions with cocaine and immune responses in mice.
The Journal of pharmacology and experimental therapeutics 2007;320(2):926-33.
2007: Tammy Wade-Galuska; Chad M Galuska; Gail Winger; James H Woods
Aspartame demand in rhesus monkeys: effects of volume and concentration manipulations.
Behavioural processes 2007;74(1):71-8.
2006: Ziva D Cooper; Diwahar Narasimhan; Roger K Sunahara; Pawel Mierzejewski; Emily Jutkiewicz; Nicholas A Larsen; Ian A Wilson; Donald W Landry; James H Woods
Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase.
Molecular pharmacology 2006;70(6):1885-91.
2006: Susan K Wood; Robert E Verhoeven; Aaron Z Savit; Kenner C Rice; Peter S Fischbach; James H Woods
Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(12):2580-90.
2006: Chad M Galuska; Gail Winger; Steven R Hursh; James H Woods
Assessing unit-price related remifentanil choice in rhesus monkeys.
Journal of the experimental analysis of behavior 2006;86(2):181-95.
2006: Mei-Chuan Ko; Hui Wei; James H Woods; Robert T Kennedy
Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies.
The Journal of pharmacology and experimental therapeutics 2006;318(3):1257-64.
2006: Nick P R Nieland; Humphrey A Moynihan; Simon Carrington; Jillian H Broadbear; James H Woods; John R Traynor; Stephen M Husbands; John W Lewis
Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones.
Journal of medicinal chemistry 2006;49(17):5333-8.
2006: Gail Winger; Chad M Galuska; Steven R Hursh; James H Woods
Relative reinforcing effects of cocaine, remifentanil, and their combination in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 2006;318(1):223-9.
2006: Emily Jutkiewicz; Michelle G Baladi; John E Folk; Kenner C Rice; James H Woods
The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol.
The Journal of pharmacology and experimental therapeutics 2006;317(3):1337-48.
2006: Emily Jutkiewicz; Mary M Torregrossa; Katarzyna Sobczyk-Kojiro; Henry I Mosberg; John E Folk; Kenner C Rice; Stanley J Watson Jr; James H Woods
Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects.
European journal of pharmacology 2006;531(1-3):151-9.
2006: Huina Zhang; Mary M Torregrossa; Emily Jutkiewicz; Yong-Gong Shi; Kenner C Rice; James H Woods; Stanley J Watson Jr; Mei-Chuan Ko
Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.
The European journal of neuroscience 2006;23(4):984-94.
2006: Mei-Chuan Ko; Mary F Divin; Heeseung Lee; James H Woods; John R Traynor
Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey.
The Journal of pharmacology and experimental therapeutics 2006;316(2):772-9.
2006: Mary M Torregrossa; Emily Jutkiewicz; Henry I Mosberg; Gianfranco Balboni; Stanley J Watson Jr; James H Woods
Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats.
Brain research 2006;1069(1):172-81.
2006: William E Fantegrossi; A W Harrington; Christina Lynn Kiessel; Justin R Eckler; Richard A Rabin; Jerrold C Winter; Andrew Coop; Kenner C Rice; James H Woods
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
Pharmacology, biochemistry, and behavior 2006;83(1):122-9.
2005: William E Fantegrossi; Kelly M Kugle; Leander J Valdes; Masato Koreeda; James H Woods
Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
Behavioural pharmacology 2005;16(8):627-33.
2005: Gail Winger; James H Woods; Chad M Galuska; Tammy Wade-Galuska
Behavioral perspectives on the neuroscience of drug addiction.
Journal of the experimental analysis of behavior 2005;84(3):667-81.
2005: Mary M Torregrossa; John E Folk; Kenner C Rice; Stanley J Watson Jr; James H Woods
Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats.
Psychopharmacology 2005;183(1):31-40.
2005: Emily Jutkiewicz; Kenner C Rice; John R Traynor; James H Woods
Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats.
Psychopharmacology 2005;182(4):588-96.
2005: Emily Jutkiewicz; Sarah T Kaminsky; Kenner C Rice; John R Traynor; James H Woods
Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.
The Journal of pharmacology and experimental therapeutics 2005;315(1):414-22.
2005: Chad M Galuska; James H Woods
Acquisition of cocaine self-administration with unsignaled delayed reinforcement in rhesus monkeys.
Journal of the experimental analysis of behavior 2005;84(2):269-80.
2005: William E Fantegrossi; Christina Lynn Kiessel; Richard De La Garza; James H Woods
Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
Psychopharmacology 2005;181(3):529-36.
2005: William E Fantegrossi; Andrew W Harrington; Justin R Eckler; Sadia Arshad; Richard A Rabin; Jerrold C Winter; Andrew Coop; Kenner C Rice; James H Woods
Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
Psychopharmacology 2005;181(3):496-503.
2005: Gregory Collins; Jeffrey M Witkin; Amy Hauck Newman; Kjell A Svensson; Peter Grundt; Jianjing Cao; James H Woods
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
The Journal of pharmacology and experimental therapeutics 2005;314(1):310-9.
2005: Emily Jutkiewicz; Susan K Wood; Hani Houshyar; Ling-Wei Hsin; Kenner C Rice; James H Woods
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats.
Psychopharmacology 2005;180(2):215-23.
2005: Emily Jutkiewicz; Nicholas P Walker; John E Folk; Kenner C Rice; Philip S Portoghese; James H Woods; John R Traynor
Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats.
The Journal of pharmacology and experimental therapeutics 2005;312(3):1314-20.
2005: Stephen M Husbands; Claire L Neilan; Jillian H Broadbear; Peter Grundt; Simon Breeden; Mario D Aceto; James H Woods; John W Lewis; John R Traynor
BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.
European journal of pharmacology 2005;509(2-3):117-25.
2005: William E Fantegrossi; Gail Winger; James H Woods; William L Woolverton; Andrew Coop
Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.
Drug and alcohol dependence 2005;77(2):161-8.
2005: Steven R Hursh; Chad M Galuska; Gail Winger; James H Woods
The economics of drug abuse: a quantitative assessment of drug demand.
Molecular interventions 2005;5(1):20-8.
2005: William E Fantegrossi; Mei-Chuan Ko; James H Woods; E Richelson
Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.
Pharmacology, biochemistry, and behavior 2005;80(2):341-9.
2005: Jillian H Broadbear; Gail Winger; James H Woods
Self-administration of methohexital, midazolam and ethanol: effects on the pituitary-adrenal axis in rhesus monkeys.
Psychopharmacology 2005;178(1):83-91.
2004: Jillian H Broadbear; Gail Winger; James H Woods
Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys.
Psychopharmacology 2004;176(3-4):398-406.
2004: Claire L Neilan; Stephen M Husbands; Simon Breeden; Mei-Chuan Ko; Mario D Aceto; John W Lewis; James H Woods; John R Traynor
Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
European journal of pharmacology 2004;499(1-2):107-16.
2004: William E Fantegrossi; William L Woolverton; Michael R Kilbourn; Phillip Sherman; Jie Yuan; George Hatzidimitriou; George A Ricaurte; James H Woods; Gail Winger
Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(7):1270-81.
2004: Jillian H Broadbear; Gail Winger; Jean E Rivier; Kenner C Rice; James H Woods
Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(6):1112-21.
2004: William E Fantegrossi; Christina Lynn Kiessel; P Tarn Leach; C Van Martin; Rachel Lynn Karabenick; X Chen; Y Ohizumi; Thomas Ullrich; Kenner C Rice; James H Woods
Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.
Psychopharmacology 2004;173(3-4):270-7.
2004: Keith L Williams; Jillian H Broadbear; James H Woods
Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
Alcoholism, clinical and experimental research 2004;28(4):566-71.
2004: Emily Jutkiewicz; Erik B Eller; John E Folk; Kenner C Rice; John R Traynor; James H Woods
Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats.
The Journal of pharmacology and experimental therapeutics 2004;309(1):173-81.
2004: Mary M Torregrossa; Ceylan Isgor; John E Folk; Kenner C Rice; Stanley J Watson Jr; James H Woods
The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(4):649-59.
2004: William E Fantegrossi; James H Woods; Gail Winger
Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.
Behavioural pharmacology 2004;15(2):149-57.
2004: Wallace B Mendelson; Thomas Roth; James Cassella; Timothy Roehrs; James K Walsh; James H Woods; Daniel J Buysse; Roger E Meyer
The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium.
Sleep medicine reviews 2004;8(1):7-17.
2004: Hui Wei; Kerstin Nolkrantz; David H Powell; James H Woods; Mei-Chuan Ko; Robert T Kennedy
Electrospray sample deposition for matrix-assisted laser desorption/ionization (MALDI) and atmospheric pressure MALDI mass spectrometry with attomole detection limits.
Rapid communications in mass spectrometry : RCM 2004;18(11):1193-200.
2004: Kathryn K Chadman; James H Woods
Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon.
The Journal of pharmacology and experimental therapeutics 2004;308(1):73-8.
2003: Emily Jutkiewicz; Kenner C Rice; James H Woods; P J Winsauer
Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats.
Behavioural pharmacology 2003;14(7):509-16.
2003: H Lee; Norah N Naughton; James H Woods; Mei-Chuan Ko
Characterization of scratching responses in rats following centrally administered morphine or bombesin.
Behavioural pharmacology 2003;14(7):501-8.
2003: Mark K Greenwald; Chris-Ellyn Johanson; David E Moody; James H Woods; Michael R Kilbourn; Robert A Koeppe; Charles R Schuster; Jon K Zubieta
Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(11):2000-9.
2003: Mei-Chuan Ko; KJ Willmont; Heeseung Lee; Graham S Flory; James H Woods
Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.
Brain research 2003;982(1):38-44.
2003: Mei-Chuan Ko; Heeseung Lee; Charlotte Harrison; Mary J Clark; H F Song; Norah N Naughton; James H Woods; John R Traynor
Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
The Journal of pharmacology and experimental therapeutics 2003;306(1):179-86.
2003: K L Williams; Mei-Chuan Ko; K C Rice; James H Woods
Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
Psychoneuroendocrinology 2003;28(4):513-28.
2003: Elisabeth Greiner; Mariana Spetea; Roland Krassnig; Falko Schüllner; Mario D Aceto; Louis S Harris; John R Traynor; James H Woods; Andrew Coop; Helmut Schmidhammer
Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.
Journal of medicinal chemistry 2003;46(9):1758-63.
2003: Mei-Chuan Ko; Heeseung Lee; Michael S Song; Katarzyna Sobczyk-Kojiro; Henry I Mosberg; Shiroh Kishioka; James H Woods; Norah N Naughton
Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
The Journal of pharmacology and experimental therapeutics 2003;305(1):173-9.
2003: William E Fantegrossi; Tomek Godlewski; Rachel L Karabenick; Jermaine M Stephens; Thomas Ullrich; Kenner C Rice; James H Woods
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
Psychopharmacology 2003;166(3):202-11.
2003: Graham S Flory; James H Woods
The ascending limb of the cocaine dose-response curve for reinforcing effect in rhesus monkeys.
Psychopharmacology 2003;166(1):91-4.
2003: Everette L May; Andrew Coop; James H Woods; Mario D Aceto; Edward R Bowman; Louis S Harris; John R Traynor
N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidones.
Bioorganic & medicinal chemistry 2003;11(1):31-3.
2002: Jillian H Broadbear; Gail Winger; Kenner C Rice; James H Woods
Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys.
Psychopharmacology 2002;164(3):268-76.
2002: Daniel C Broom; Joshua F Nitsche; John E Pintar; Kenner C Rice; James H Woods; John R Traynor
Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
The Journal of pharmacology and experimental therapeutics 2002;303(2):723-9.
2002: James H Woods; Charles France
Determinants of the behavioral effects of opioids and their antagonists: contributions of the Laboratory of Psychobiology.
Psychopharmacology 2002;163(3-4):406-11.
2002: James H Woods; Gail Winger
Observing responses maintained by stimuli associated with cocaine or remifentanil reinforcement in rhesus monkeys.
Psychopharmacology 2002;163(3-4):345-51.
2002: Daniel C Broom; Emily Jutkiewicz; John E Folk; John R Traynor; Kenner C Rice; James H Woods
Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats.
Psychopharmacology 2002;164(1):42-8.
2002: Daniel C Broom; Emily Jutkiewicz; Kenner C Rice; John R Traynor; James H Woods
Behavioral effects of delta-opioid receptor agonists: potential antidepressants?
Japanese journal of pharmacology 2002;90(1):1-6.
2002: William E Fantegrossi; Thomas Ullrich; Kenner C Rice; James H Woods; Gail Winger
3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.
Psychopharmacology 2002;161(4):356-64.
2002: Lee Koetzner; James H Woods
Characterization of equine butyrylcholinesterase disposition in the mouse.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(6):724-30.
2002: Lee Koetzner; James H Woods
Characterization of butyrylcholinesterase antagonism of cocaine-induced hyperactivity.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(6):716-23.
2002: Daniel C Broom; Emily Jutkiewicz; John E Folk; John R Traynor; Kenner C Rice; James H Woods
Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(6):744-55.
2002: Mei-Chuan Ko; J Terner; Steven R Hursh; James H Woods; Gail Winger
Relative reinforcing effects of three opioids with different durations of action.
The Journal of pharmacology and experimental therapeutics 2002;301(2):698-704.
2002: Gail Winger; Steven R Hursh; K L Casey; James H Woods
Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action.
The Journal of pharmacology and experimental therapeutics 2002;301(2):690-7.
2002: Mei-Chuan Ko; Norah N Naughton; John R Traynor; Michael S Song; James H Woods; Kenner C Rice; A T McKnight
Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors.
British journal of pharmacology 2002;135(4):943-50.
2002: Lee Koetzner; Tina L Sumpter; James H Woods
Tetrabenazine fails to antagonize a behavioral effect of cocaine in rhesus monkeys.
Pharmacology, biochemistry, and behavior 2002;71(1-2):1-5.
2002: A Alt; Mary J Clark; James H Woods; John R Traynor
Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.
British journal of pharmacology 2002;135(1):217-25.
2001: Karen G Anderson; Gail Winger; James H Woods; William L Woolverton
Reinforcing and discriminative-stimulus effects of ephedrine isomers in rhesus monkeys.
Drug and alcohol dependence 2001;65(1):45-53.
2001: Hani Houshyar; Mario D Galigniana; William B Pratt; James H Woods
Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses.
Journal of neuroendocrinology 2001;13(10):875-86.
2001: Hani Houshyar; Ziva D Cooper; James H Woods
Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm.
Journal of neuroendocrinology 2001;13(10):862-74.
2001: KL Williams; E C Kane; James H Woods
Interaction of morphine and naltrexone on oral ethanol self-administration in rhesus monkeys.
Behavioural pharmacology 2001;12(5):325-33.
2001: Eduardo R Butelman; Mei-Chuan Ko; John R Traynor; JA Vivian; Mary Jeanne Kreek; James H Woods
GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 2001;298(3):1049-59.
2001: A Alt; IJ McFadyen; C D Fan; James H Woods; John R Traynor
Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
The Journal of pharmacology and experimental therapeutics 2001;298(1):116-21.
2001: RJ Briscoe; PM Jeanville; C Cabrera; T J Baird; James H Woods; D W Landry
A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis.
International immunopharmacology 2001;1(6):1189-98.
2001: Lisa Gerak; William L Woolverton; M A Nader; G A Patrick; L S Harris; Gail Winger; James H Woods; Charles France
Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats.
Drug and alcohol dependence 2001;63(1):39-49.
2001: James H Woods
How does regulation of drug intake come about? Comment on Lynch and Carroll (2001).
Experimental and clinical psychopharmacology 2001;9(2):155-6; discussion 160-2.
2001: Gail Winger; James H Woods
The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys.
Drug and alcohol dependence 2001;62(3):181-9.
2001: Lee Koetzner; S Deng; Tina L Sumpter; M Weisslitz; R T Abner; Donald W Landry; James H Woods
Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 2001;296(3):789-96.
2000: Everette L May; Arthur E Jacobson; M V Mattson; John R Traynor; James H Woods; Louis S Harris; Edward R Bowman; Mario D Aceto
Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues.
Journal of medicinal chemistry 2000;43(26):5030-6.
2000: TJ Baird; Shi-Xian Deng; Donald W Landry; Gail Winger; James H Woods
Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1127-34.
2000: Andrew Coop; Arthur E Jacobson; Mario D Aceto; Louis S Harris; John R Traynor; James H Woods; Kenner C Rice
N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole.
Bioorganic & medicinal chemistry letters 2000;10(21):2449-51.
2000: RJ Briscoe; C L Cabrera; TJ Baird; Kenner C Rice; James H Woods
Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats.
Brain research 2000;881(2):204-7.
2000: PM Jeanville; James H Woods; T J Baird; ES Estapé
Direct determination of ecgonine methyl ester and cocaine in rat plasma, utilizing on-line sample extraction coupled with rapid chromatography/quadrupole orthogonal acceleration time-of-flight detection.
Journal of pharmaceutical and biomedical analysis 2000;23(5):897-907.
2000: IJ McFadyen; Hani Houshyar; L Y Liu-Chen; James H Woods; John R Traynor
The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore.
Molecular pharmacology 2000;58(4):669-76.
2000: Daniel C Broom; L Guo; Andrew Coop; Stephen M Husbands; John W Lewis; James H Woods; John R Traynor
BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
The Journal of pharmacology and experimental therapeutics 2000;294(3):1195-200.
2000: Jillian H Broadbear; Tina L Sumpter; T F Burke; Stephen M Husbands; John W Lewis; James H Woods; John R Traynor
Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
The Journal of pharmacology and experimental therapeutics 2000;294(3):933-40.
2000: Jon K Zubieta; Mark K Greenwald; U Lombardi; James H Woods; Michael R Kilbourn; Douglas M Jewett; Robert A Koeppe; Charles R Schuster; Chris-Ellyn Johanson
Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;23(3):326-34.
2000: I Derrick; Claire L Neilan; J Andes; Stephen M Husbands; James H Woods; John R Traynor; John W Lewis
3-Deoxyclocinnamox: the first high-affinity, nonpeptide mu-opioid antagonist lacking a phenolic hydroxyl group.
Journal of medicinal chemistry 2000;43(17):3348-50.
2000: Mei-Chuan Ko; KJ Willmont; A Burritt; Victor J Hruby; James H Woods
Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys.
European journal of pharmacology 2000;402(1-2):69-76.
2000: James H Woods
The next reinforcer: comment on Meisch (2000)
Experimental and clinical psychopharmacology 2000;8(3):360-1; discussion 362-5.
2000: KL Williams; James H Woods
A behavioral economic analysis of concurrent ethanol- and water-reinforced responding in different preference conditions.
Alcoholism, clinical and experimental research 2000;24(7):980-6.
2000: S Kishioka1; C A Paronis2; James H Woods
Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys.
European journal of pharmacology 2000;398(1):121-30.
2000: Shiroh Kishioka; Mei-Chuan Ko; James H Woods
Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys.
European journal of pharmacology 2000;397(1):85-92.
2000: Ann E Remmers; Mary J Clark; A Alt; F Medzihradsky; James H Woods; John R Traynor
Activation of G protein by opioid receptors: role of receptor number and G-protein concentration.
European journal of pharmacology 2000;396(2-3):67-75.
2000: Hani Houshyar; I J Mc Fadyen; James H Woods; John R Traynor
Antinociceptive and other behavioral effects of the steroid SC17599 are mediated by the mu-opioid receptor.
European journal of pharmacology 2000;395(2):121-8.
2000: Shiroh Kishioka; C A Paronis; John W Lewis; James H Woods
Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys.
European journal of pharmacology 2000;391(3):289-97.
2000: RJ Briscoe; Gail Winger; John W Lewis; James H Woods
Methoclocinnamox: time course of changes in alfentanil-reinforced responding in rhesus monkeys.
Psychopharmacology 2000;148(4):393-9.
2000: James H Woods
Looking to the future of behavioral pharmacology while being attentive to its past.
Experimental and clinical psychopharmacology 2000;8(1):147-9.
2000: Mei-Chuan Ko; J E Tuchman; M D Johnson; K Wiesenauer; James H Woods
Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
Psychopharmacology 2000;148(2):180-5.
1999: Mei-Chuan Ko; M D Johnson; Eduardo R Butelman; KJ Willmont; Henry I Mosberg; James H Woods
Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1113-20.
1999: John R Traynor; L Guo; Andrew Coop; J W Lewis; James H Woods
Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1093-9.
1999: JA Vivian; Y J Liang; J D Higley; M Linnoila; James H Woods
Oral self-administration of ethanol, phencyclidine, methadone, pentobarbital and quinine in rhesus monkeys.
Psychopharmacology 1999;147(2):113-24.
1999: Jillian H Broadbear; Gail Winger; James H Woods
Glucocorticoid-reinforced responding in the rhesus monkey.
Psychopharmacology 1999;147(1):46-55.
1999: Claire L Neilan; Huda Akil; James H Woods; John R Traynor
Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists.
British journal of pharmacology 1999;128(3):556-62.
1999: KL Williams; James H Woods
Naltrexone reduces ethanol- and/or water-reinforced responding in rhesus monkeys: effect depends upon ethanol concentration.
Alcoholism, clinical and experimental research 1999;23(9):1462-7.
1999: Jillian H Broadbear; Gail Winger; James H Woods
Cocaine-reinforced responding in rhesus monkeys: pharmacological attenuation of the hypothalamic-pituitary-adrenal axis response.
The Journal of pharmacology and experimental therapeutics 1999;290(3):1347-55.
1999: M D Johnson; M C H Ko; Mei-Chuan Ko; John R Traynor; Henry I Mosberg; Norah N Naughton; James H Woods
The effects of the phyllolitorin analogue [desTrp(3), Leu(8)]phyllolitorin on scratching induced by bombesin and related peptides in rats.
Brain research 1999;839(1):194-8.
1999: K O Lee; Huda Akil; James H Woods; John R Traynor
Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.
European journal of pharmacology 1999;378(3):323-30.
1999: JA Vivian; J D Higley; M Linnoila; James H Woods
Oral ethanol self-administration in rhesus monkeys: behavioral and neurochemical correlates.
Alcoholism, clinical and experimental research 1999;23(8):1352-61.
1999: James K Rowlett; Gail Winger; Richard Carter; PL Wood; James H Woods; William L Woolverton
Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys.
Psychopharmacology 1999;145(2):205-12.
1999: Jillian H Broadbear; Gail Winger; Theodore J Cicero; James H Woods
Effects of response contingent and noncontingent cocaine injection on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;290(1):393-402.
1999: JA Vivian; M B DeYoung; Tina L Sumpter; John R Traynor; John W Lewis; James H Woods
kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;290(1):259-65.
1999: KL Williams; ED Pakarinen; James H Woods
Quadazocine decreases responding reinforced by ethanol, sucrose, and phencyclidine fluid deliveries in rhesus monkeys: comparison to naltrexone's effects.
Psychopharmacology 1999;144(4):316-22.
1999: Jillian H Broadbear; Gail Winger; Theodore J Cicero; James H Woods
Effects of self-administered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;289(3):1641-7.
1999: JA Vivian; Tina L Sumpter; James H Woods
Further characterization of the quinine taste discrimination stimulus in rhesus monkeys: effects of inter-trial interval, number and distribution of test stimuli.
Behavioural pharmacology 1999;10(3):313-8.
1999: Mei-Chuan Ko; James H Woods
Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action.
Psychopharmacology 1999;143(3):322-6.
1999: Eduardo R Butelman; JA Vivian; J Yu; Mary Jeanne Kreek; James H Woods
Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys.
Psychopharmacology 1999;143(2):190-6.
1999: KL Williams; James H Woods
Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys.
Alcoholism, clinical and experimental research 1999;23(4):708-15.
1999: William L Woolverton; James K Rowlett; Gail Winger; James H Woods; Lisa Gerak; Charles France
Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys.
Drug and alcohol dependence 1999;54(2):137-43.
1999: C M Campbell; Eduardo R Butelman; James H Woods
Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites.
The Journal of pharmacology and experimental therapeutics 1999;289(1):521-7.
1999: Mei-Chuan Ko; Eduardo R Butelman; James H Woods
Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;289(1):378-85.
1999: Ann E Remmers; Mary J Clark; A Mansour; Huda Akil; James H Woods; F Medzihradsky
Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor.
The Journal of pharmacology and experimental therapeutics 1999;288(2):827-33.
1999: J Aspen; M B Gatch; James H Woods
Training and characterization of a quinine taste discrimination in rhesus monkeys.
Psychopharmacology 1999;141(3):251-7.
1999: ED Pakarinen; KL Williams; James H Woods
Food restriction and sex differences on concurrent, oral ethanol and water reinforcers in juvenile rhesus monkeys.
Alcohol (Fayetteville, N.Y.) 1999;17(1):35-40.
1998: KL Williams; James H Woods
Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor.
Alcoholism, clinical and experimental research 1998;22(8):1634-9.
1998: KL Williams; Gail Winger; ED Pakarinen; James H Woods
Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys.
Psychopharmacology 1998;139(1-2):53-61.
1998: James H Woods
Problems and opportunities in regulation of benzodiazepines.
Journal of clinical pharmacology 1998;38(9):773-82.
1998: Stephen M Husbands; J Sadd; Jillian H Broadbear; James H Woods; J Martin; John R Traynor; Mario D Aceto; Edward R Bowman; Louis S Harris; John W Lewis
3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy.
Journal of medicinal chemistry 1998;41(18):3493-8.
1998: Berend Mets; Gail Winger; C Cabrera; S Seo; SC Jamdar; G Yang; K Zhao; RJ Briscoe; R Almonte; James H Woods; Donald W Landry
A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(17):10176-81.
1998: JA Vivian; Shiroh Kishioka; Eduardo R Butelman; Jillian H Broadbear; K O Lee; James H Woods
Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
The Journal of pharmacology and experimental therapeutics 1998;286(2):697-703.
1998: P B Lieberman; James H Woods; Elizabeth A Young
The role of endogenous opioids in the luteinizing hormone surge in rats: studies with clocinnamox, a long-lasting opioid receptor antagonist.
European journal of pharmacology 1998;352(1):73-9.
1998: A Alt; A Mansour; Huda Akil; F Medzihradsky; John R Traynor; James H Woods
Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.
The Journal of pharmacology and experimental therapeutics 1998;286(1):282-8.
1998: Mei-Chuan Ko; Eduardo R Butelman; James H Woods
The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1998;286(1):150-6.
1998: Eduardo R Butelman; Mei-Chuan Ko; Katarzyna Sobczyk-Kojiro; Henry I Mosberg; B Van Bemmel; G Zernig; James H Woods
kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception.
The Journal of pharmacology and experimental therapeutics 1998;285(2):595-601.
1998: Mei-Chuan Ko; Eduardo R Butelman; John R Traynor; James H Woods
Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1998;285(2):518-26.
1998: James H Woods
Toward an account of individual differences in drug abuse.
NIDA research monograph 1998;169():2-5.
1998: Charles France; Lisa Gerak; J K Rowlett; William L Woolverton; Gail Winger; James H Woods
Progress report from the testing program for stimulant and depressant drugs (1996).
NIDA research monograph 1998;178():429-39.
1998: James H Woods; F Medzihradsky; Charles B Smith; Gail Winger; John R Traynor
Evaluation of new compounds for opioid activity (1997).
NIDA research monograph 1998;178():408-28.
1998: Gregory I Elmer; Jeanne O Pieper; S Stevens Negus; James H Woods
Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests.
Pain 1998;75(1):129-40.
1998: S A Vanecek; W D Essman; D P Taylor; James H Woods
Discriminative stimulus characteristics of BMY 14802 in the pigeon.
The Journal of pharmacology and experimental therapeutics 1998;284(1):1-9.
1997: Mary J Clark; PJ Emmerson; A Mansour; Huda Akil; James H Woods; Philip S Portoghese; Ann E Remmers; F Medzihradsky
Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
The Journal of pharmacology and experimental therapeutics 1997;283(2):501-10.
1997: CA Paronis; James H Woods
Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.
European journal of pharmacology 1997;337(1):27-34.
1997: J Yu; Eduardo R Butelman; James H Woods; Brian T Chait; Mary Jeanne Kreek
Dynorphin A (1-8) analog, E-2078, crosses the blood-brain barrier in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1997;282(2):633-8.
1997: CA Paronis; James H Woods
Ventilation in morphine-maintained rhesus monkeys. II: Tolerance to the antinociceptive but not the ventilatory effects of morphine.
The Journal of pharmacology and experimental therapeutics 1997;282(1):355-62.
1997: CA Paronis; James H Woods
Ventilation in morphine-maintained rhesus monkeys. I: Effects of naltrexone and abstinence-associated withdrawal.
The Journal of pharmacology and experimental therapeutics 1997;282(1):348-54.
1997: James H Woods; Gail Winger
Abuse liability of flunitrazepam.
Journal of clinical psychopharmacology 1997;17(3 Suppl 2):1S-57S.
1997: J Yu; Eduardo R Butelman; James H Woods; Brian T Chait; Mary Jeanne Kreek
Dynorphin A (1-8) analog, E-2078, is stable in human and rhesus monkey blood.
The Journal of pharmacology and experimental therapeutics 1997;280(3):1147-51.
1997: G Zernig; John W Lewis; James H Woods
Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception.
Psychopharmacology 1997;129(3):233-42.
1996: Eduardo R Butelman; John W Lewis; James H Woods
Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1996;279(2):934-8.
1996: J Yu; Eduardo R Butelman; James H Woods; Brian T Chait; Mary Jeanne Kreek
In vitro biotransformation of dynorphin A (1-17) is similar in human and rhesus monkey blood as studied by matrix-assisted laser desorption/ionization mass spectrometry.
The Journal of pharmacology and experimental therapeutics 1996;279(2):507-14.
1996: D C Jewett; Henry I Mosberg; James H Woods
Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons.
Psychopharmacology 1996;127(3):225-30.
1996: M D Acteo; E Bowman; Eduardo R Butelman; J A Englis; L Harrish; A E Jacobson; M V Mattson; F Medzihradsky; G Patrick; James K Rowlett; Charles B Smith; Gail Winger; James H Woods; William L Woolverton
Zipeprol: preclinical assessment of abuse potential.
Drug and alcohol dependence 1996;42(2):93-104.
1996: G Zernig; T Burke; John W Lewis; James H Woods
Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
The Journal of pharmacology and experimental therapeutics 1996;279(1):23-31.
1996: P J Emmerson; Mary J Clark; A Mansour; Huda Akil; James H Woods; F Medzihradsky
Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.
The Journal of pharmacology and experimental therapeutics 1996;278(3):1121-7.
1996: G Zernig; T Issaevitch; James H Woods
Calculation of agonist efficacy, apparent affinity, and receptor population changes after administration of insurmountable antagonists: comparison of different analytical approaches.
Journal of pharmacological and toxicological methods 1996;35(4):223-37.
1996: D C Jewett; Eduardo R Butelman; James H Woods
Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons.
Brain research 1996;715(1-2):25-31.
1996: I Derrick; John W Lewis; H A Moynihan; Jillian Broadbear; James H Woods
Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of beta-naltrexamine.
The Journal of pharmacy and pharmacology 1996;48(2):192-6.
1996: Eduardo R Butelman; S Stevens Negus; John W Lewis; James H Woods
Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys.
Psychopharmacology 1996;123(4):320-4.
1995: Eduardo R Butelman; Charles France; James H Woods
Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1995;275(1):374-80.
1995: S Stevens Negus; Eduardo R Butelman; Michael B Gatch; James H Woods
Effects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1995;274(2):805-14.
1995: Charles France; Lisa Gerak; D Flynn; Gail Winger; F Medzihradsky; JR Bagley; LL Brockunier; James H Woods
Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1995;274(1):17-28.
1995: Ellen A Walker; G Zernig; James H Woods
Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.
The Journal of pharmacology and experimental therapeutics 1995;273(3):1345-52.
1995: Eduardo R Butelman; S Stevens Negus; Michael B Gatch; K J Chang; James H Woods
BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys.
European journal of pharmacology 1995;277(2-3):285-7.
1995: James H Woods; Gail Winger
Current benzodiazepine issues.
Psychopharmacology 1995;118(2):107-15; discussion 118, 120-1.
1995: S P Baron; James H Woods
Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine.
Psychopharmacology 1995;118(1):42-51.
1995: Eduardo R Butelman; Gail Winger; G Zernig; James H Woods
Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1995;272(2):845-53.
1995: E D Pakarinen; James H Woods; Joseph M Moerschbaecher
Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.
The Journal of pharmacology and experimental therapeutics 1995;272(2):552-9.
1995: James H Woods; John W Lewis; Gail Winger; Eduardo R Butelman; Jillian H Broadbear; G Zernig
Methoclocinnamox: a mu partial agonist with pharmacotherapeutic potential for heroin abuse.
NIDA research monograph 1995;147():195-219.
1995: G Zernig; T Issaevitch; Jillian H Broadbear; T F Burke; John W Lewis; G A Brine; James H Woods
Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding.
Life sciences 1995;57(23):2113-25.
1994: P J Emmerson; M R Liu; James H Woods; F Medzihradsky
Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
The Journal of pharmacology and experimental therapeutics 1994;271(3):1630-7.
1994: Lisa Gerak; Eduardo R Butelman; James H Woods; Charles France
Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1994;271(2):993-9.
1994: T F Burke; James H Woods; John W Lewis; F Medzihradsky
Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
The Journal of pharmacology and experimental therapeutics 1994;271(2):715-21.
1994: S Stevens Negus; Eduardo R Butelman; K J Chang; B DeCosta; Gail Winger; James H Woods
Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1994;270(3):1025-34.
1994: Jillian H Broadbear; S Stevens Negus; Eduardo R Butelman; B R de Costa; James H Woods
Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay.
Psychopharmacology 1994;115(3):311-9.
1994: G Zernig; Eduardo R Butelman; John W Lewis; Ellen A Walker; James H Woods
In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
The Journal of pharmacology and experimental therapeutics 1994;269(1):57-65.
1994: G A Patrick; Louis S Harris; William L Woolverton; M A Nader; Gail Winger; James H Woods
Progress report from the testing program for stimulant and depressant drugs (1993).
NIDA research monograph 1994;140():248-63.
1994: James H Woods; Charles France; F Medzihradsky; Charles B Smith; Gail Winger
Evaluation of new compounds for opioid activity annual report (1993).
NIDA research monograph 1994;140():196-247.
1994: Charles France; F Medzihradsky; James H Woods
Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities.
The Journal of pharmacology and experimental therapeutics 1994;268(1):47-58.
1993: Eduardo R Butelman; S Stevens Negus; Y Ai; B R de Costa; James H Woods
Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1993;267(3):1269-76.
1993: S Stevens Negus; T F Burke; F Medzihradsky; James H Woods
Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
The Journal of pharmacology and experimental therapeutics 1993;267(2):896-903.
1993: S D Comer; E M Hoenicke; A I Sable; R W McNutt; K J Chang; B R De Costa; Henry I Mosberg; James H Woods
Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.
The Journal of pharmacology and experimental therapeutics 1993;267(2):888-95.
1993: S D Comer; R W McNutt; K J Chang; B R De Costa; Henry I Mosberg; James H Woods
Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
The Journal of pharmacology and experimental therapeutics 1993;267(2):866-74.
1993: Ellen A Walker; Eduardo R Butelman; B R DeCosta; James H Woods
Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
The Journal of pharmacology and experimental therapeutics 1993;267(1):280-6.
1993: S Stevens Negus; Eduardo R Butelman; Y Al; James H Woods
Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1355-63.
1993: P Skjoldager; Gail Winger; James H Woods
Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys.
Drug and alcohol dependence 1993;33(1):31-9.
1993: Eduardo R Butelman; James H Woods
Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1993;264(2):762-9.
1993: S P Baron; James H Woods
Dipsogenic effects of excitatory amino acid agonists in pigeons.
The Journal of pharmacology and experimental therapeutics 1993;264(2):918-21.
1993: James H Woods; Charles France; F Medzihradsky; Charles B Smith; Gail Winger
Evaluation of new compounds for opioid activity, 1992.
NIDA research monograph 1993;132():517-78.
1993: William L Woolverton; M A Nader; Gail Winger; James H Woods; G A Patrick; Louis S Harris
Progress report from the testing program for stimulant and depressant drug (1992).
NIDA research monograph 1993;132():579-94.
1993: Eduardo R Butelman; Charles France; James H Woods
Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1993;264(1):145-51.
1992: Y Lu; Charles France; James H Woods
Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.
The Journal of pharmacology and experimental therapeutics 1992;263(2):499-504.
1992: Gail Winger; Charles France; James H Woods; Charles B Smith; F Medzihradsky; M A Iorio
Opioid and non-opioid effects of novel butyrophenone analogues.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1992;7(3):177-87.
1992: E M Hoenicke; S A Vanecek; James H Woods
The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
The Journal of pharmacology and experimental therapeutics 1992;263(1):276-84.
1992: S D Comer; T F Burke; John W Lewis; James H Woods
Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
The Journal of pharmacology and experimental therapeutics 1992;262(3):1051-6.
1992: James H Woods; Gail Winger; Charles France
Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability.
Trends in pharmacological sciences 1992;13(7):282-6.
1992: James H Woods; J L Katz; Gail Winger
Benzodiazepines: use, abuse, and consequences.
Pharmacological reviews 1992;44(2):151-347.
1992: Gail Winger; P Skjoldager; James H Woods
Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1992;261(1):311-7.
1992: A J Bertalmio; F Medzihradsky; Gail Winger; James H Woods
Differential influence of N-dealkylation on the stimulus properties of some opioid agonists.
The Journal of pharmacology and experimental therapeutics 1992;261(1):278-84.
1992: James H Woods; F Medzihradsky; Charles B Smith; Gail Winger; Charles France
Evaluation of new compounds for opioid activity (1991).
NIDA research monograph 1992;119():559-603.
1992: James H Woods; Charles France; Gail Winger
Behavioral pharmacology of buprenorphine: issues relevant to its potential in treating drug abuse.
NIDA research monograph 1992;121():12-27.
1992: Charles France; Gail Winger; M R Seggel; K C Rice; James H Woods
Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys.
Psychopharmacology 1992;109(3):291-8.
1992: Gail Winger; James H Woods; G A Patrick; L J Powell; Louis S Harris; M A Nader; William L Woolverton
Progress report from the Testing Program for Stimulant and Depressant Drugs (1991).
NIDA research monograph 1992;119():625-39.
1992: G A Patrick; Louis S Harris; M A Nader; William L Woolverton; Gail Winger; James H Woods
Progress report from the Testing Program for Stimulant and Depressant Drugs (1990).
NIDA research monograph 1992;119():604-24.
1992: A J Bertalmio; James H Woods
Discriminative stimulus effects of cyclorphan: selective antagonism with naltrexone.
Psychopharmacology 1992;106(2):189-94.
1991: Ellen A Walker; T Yamamoto; P J Hollingsworth; Charles B Smith; James H Woods
Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
The Journal of pharmacology and experimental therapeutics 1991;259(2):772-82.
1991: P Skjoldager; Gail Winger; James H Woods
Analysis of fixed-ratio behavior maintained by drug reinforcers.
Journal of the experimental analysis of behavior 1991;56(2):331-43.
1991: T Yamamoto; Ellen A Walker; James H Woods
Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
The Journal of pharmacology and experimental therapeutics 1991;258(3):999-1007.
1991: Charles France; Gail Winger; F Medzihradsky; M R Seggel; K C Rice; James H Woods
Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
The Journal of pharmacology and experimental therapeutics 1991;258(2):502-10.
1991: Charles France; Joseph M Moerschbaecher; James H Woods
MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination.
The Journal of pharmacology and experimental therapeutics 1991;257(2):727-34.
1991: James H Woods; J L Katz; Gail Winger
Restricting benzodiazepine prescribing.
Lancet 1991;337(8736):295.
1991: M A Nader; Gail Winger; James H Woods; William L Woolverton
Discriminative and reinforcing effects of brotizolam in rhesus monkeys.
Psychopharmacology 1991;103(2):166-71.
1991: S D Comer; Charles France; James H Woods
Training dose: influences in opioid drug discrimination.
NIDA research monograph 1991;(116):145-61.
1990: Charles France; Y Lu; James H Woods
Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons.
The Journal of pharmacology and experimental therapeutics 1990;255(3):1271-7.
1990: Charles France; Gail Winger; James H Woods
Analgesic, anesthetic, and respiratory effects of the competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 in rhesus monkeys.
Brain research 1990;526(2):355-8.
1990: Charles France; James H Woods
Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons.
The Journal of pharmacology and experimental therapeutics 1990;254(2):626-32.
1990: A Thurkauf; B de Costa; M V Mattson; Charles France; M T Price; J W Olney; James H Woods; Arthur E Jacobson; Kenner C Rice
Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines.
Journal of medicinal chemistry 1990;33(8):2211-5.
1990: Wouter Koek; James H Woods; F C Colpaert
N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
The Journal of pharmacology and experimental therapeutics 1990;253(3):1017-25.
1990: James H Woods
Abuse liability and the regulatory control of therapeutic drugs: untested assumptions.
Drug and alcohol dependence 1990;25(2):229-33.
1990: Charles France; B R de Costa; A E Jacobson; K C Rice; James H Woods
Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone.
The Journal of pharmacology and experimental therapeutics 1990;252(2):600-4.
1990: Charles B Smith; F Medzihradsky; P J Hollingsworth; B DeCosta; K C Rice; James H Woods
Nor-binaltorphimine is a reversible, noncompetitive opioid antagonist in the mouse vas deferens with high affinity for kappa receptors in monkey brain membranes.
Progress in clinical and biological research 1990;328():65-8.
1990: Charles France; James H Woods
Respiratory effects of receptor-selective opioids in rhesus monkeys.
Progress in clinical and biological research 1990;328():295-8.
1990: James H Woods; F Medzihradsky; Charles B Smith; Gail Winger; Charles France
Evaluation of new compounds for opioid activity (1990).
NIDA research monograph 1990;105():682-724.
1989: A J Bertalmio; James H Woods
Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis.
The Journal of pharmacology and experimental therapeutics 1989;251(2):455-60.
1989: Gail Winger; R K Palmer; James H Woods
Drug-reinforced responding: rapid determination of dose-response functions.
Drug and alcohol dependence 1989;24(2):135-42.
1989: Wouter Koek; F C Colpaert; James H Woods; Jean-Marc Kamenka
The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
The Journal of pharmacology and experimental therapeutics 1989;250(3):1019-27.
1989: Charles France; James H Woods
Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1989;250(3):937-43.
1989: Richard B Rothman; Charles France; V Bykov; B R De Costa; Arthur E Jacobson; James H Woods; Kenner C Rice
Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
European journal of pharmacology 1989;167(3):345-53.
1989: Charles France; A M Snyder; James H Woods
Analgesic effects of phencyclidine-like drugs in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1989;250(1):197-201.
1989: Mario D Aceto; Edward R Bowman; Everette L May; Louis S Harris; James H Woods; Charles B Smith; F Medzihradsky; A E Jacobson
Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives.
Arzneimittel-Forschung 1989;39(5):570-5.
1989: Charles France; James H Woods; Paul Ornstein
The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.
European journal of pharmacology 1989;159(2):133-9.
1989: Charles France; James H Woods
Naltrexone discrimination in morphine-treated monkeys.
NIDA research monograph 1989;95():298-9.
1989: James H Woods; F Medzihradsky; Charles B Smith; Gail Winger; Charles France
1989 Annual Report, evaluation of new compounds for opioid activity.
NIDA research monograph 1989;95():632-79.
1989: James H Woods; B DeCosta; A E Jacobson; K C Rice; F Medzihradsky; Charles B Smith; S Comer; Charles France; Gail Winger
Delta opioid receptor selective alkaloid agonists and antagonists.
NIDA research monograph 1989;95():300-1.
1988: James H Woods; J L Katz; Gail Winger
Use and abuse of benzodiazepines. Issues relevant to prescribing.
JAMA : the journal of the American Medical Association 1988;260(23):3476-80.
1988: Wouter Koek; James H Woods
2-Amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Neuropharmacology 1988;27(7):771-5.
1988: Wouter Koek; James H Woods; Gail Winger
MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1988;245(3):969-74.
1988: Charles France; James H Woods
Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
The Journal of pharmacology and experimental therapeutics 1988;244(2):599-605.
1988: James H Woods; F Medzihradsky; Charles B Smith; Gail Winger; D Gmerek
Evaluation of new compounds for opioid activity: 1987 annual report.
NIDA research monograph 1988;81():543-90.
1988: James H Woods; F Medzihradsky; Charles B Smith; Gail Winger; Charles France
Evaluation of new compounds for opioid activity.
NIDA research monograph 1988;90():421-67.
1988: James H Woods; A J Bertalmio; Alice M Young; W D Essman; Gail Winger
Receptor mechanisms of opioid drug discrimination.
Psychopharmacology series 1988;4():95-106.
1987: James H Woods; J L Katz; Gail Winger
Abuse liability of benzodiazepines.
Pharmacological reviews 1987;39(4):251-413.
1987: James H Woods; Gail Winger
Behavioral characterization of opioid mixed agonist-antagonists.
Drug and alcohol dependence 1987;20(4):303-15.
1987: A J Bertalmio; James H Woods
Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
The Journal of pharmacology and experimental therapeutics 1987;243(2):591-7.
1987: Arthur E Jacobson; E A Harrison; M V Mattson; M F Rafferty; Kenner C Rice; James H Woods; Gail Winger; R E Solomon; R A Lessor; J V Silverton
Enantiomeric and diastereomeric dioxadrols: behavioral, biochemical and chemical determination of the configuration necessary for phencyclidine-like properties.
The Journal of pharmacology and experimental therapeutics 1987;243(1):110-7.
1987: Wouter Koek; James H Woods; M V Mattson; A E Jacobson; P J Mudar
Excitatory amino acid antagonists induce a phencyclidine-like catalepsy in pigeons: structure-activity studies.
Neuropharmacology 1987;26(9):1261-5.
1987: L A Dykstra; D E Gmerek; Gail Winger; James H Woods
Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects.
The Journal of pharmacology and experimental therapeutics 1987;242(2):413-20.
1987: D E Gmerek; L A Dykstra; James H Woods
Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
The Journal of pharmacology and experimental therapeutics 1987;242(2):428-36.
1987: L A Dykstra; D E Gmerek; Gail Winger; James H Woods
Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
The Journal of pharmacology and experimental therapeutics 1987;242(2):421-7.
1987: Charles France; James H Woods
Morphine, saline and naltrexone discrimination in morphine-treated pigeons.
The Journal of pharmacology and experimental therapeutics 1987;242(1):195-202.
1987: Charles France; Jill Adams; James H Woods
Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons.
Neuropharmacology 1987;26(6):541-8.
1987: James H Woods; Charles B Smith; F Medzihradsky; Gail Winger; D E Gmerek
Evaluation of new compounds for opioid activity: 1986 annual report.
NIDA research monograph 1987;76():448-84.
1987: Charles France; James H Woods
Beta-funaltrexamine antagonizes the discriminative stimulus effects of morphine but not naltrexone in pigeons.
Psychopharmacology 1987;91(2):213-6.
1987: Wouter Koek; James H Woods; A E Jacobson; K C Rice
Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonovalerate in pigeons: generality across different training doses of PCP.
Psychopharmacology 1987;93(4):437-42.
1987: Wouter Koek; James H Woods; Paul Ornstein
A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats.
Psychopharmacology 1987;91(3):297-304.
1986: D E Gmerek; James H Woods
Kappa receptor mediated opioid dependence in rhesus monkeys.
Life sciences 1986;39(11):987-92.
1986: Wouter Koek; James H Woods; Paul Ornstein
Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate.
Life sciences 1986;39(11):973-8.
1986: L A Dykstra; James H Woods
A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys.
Journal of pharmacological methods 1986;15(3):263-9.
1986: Wouter Koek; James H Woods; Arthur E Jacobson; Kenner C Rice; R A Lessor
Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1986;237(2):386-92.
1986: K Takada; Gail Winger; J Cook; P Larscheid; James H Woods
Discriminative and aversive properties of beta-carboline-3-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkeys.
Life sciences 1986;38(11):1049-56.
1986: E A Young; J M Walker; M E Lewis; R A Houghten; James H Woods; Huda Akil
[3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain.
European journal of pharmacology 1986;121(3):355-65.
1986: Wouter Koek; E Kleer; P J Mudar; James H Woods
Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5-phosphonovalerate.
Behavioural brain research 1986;19(3):257-9.
1986: D E Gmerek; A Cowan; James H Woods
Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
The Journal of pharmacology and experimental therapeutics 1986;236(1):8-13.
1986: Wouter Koek; James H Woods
Response repetition in pigeons: pharmacological and behavioral specificity.
Psychopharmacology 1986;90(4):475-81.
1986: James H Woods; F Medzihradsky; Charles B Smith; Gail Winger; D E Gmerek
Evaluation of new compounds for opioid activity (1985).
NIDA research monograph 1986;67():453-89.
1986: K Takada; Gail Winger; J Cook; P Larscheid; James H Woods
Discriminative and aversive stimulus effects of beta-carboline ethyl ester in rhesus monkeys.
NIDA research monograph 1986;67():119-24.
1986: Charles B Smith; F Medzihradsky; James H Woods
Dihydromorphine-peptide hybrids have mu receptor antagonistic and delta receptor agonistic activity on the mouse vas deferens and bind with high affinity to opioid receptors in rat brain.
NIDA research monograph 1986;75():189-92.
1985: Charles France; Jill Adams; James H Woods
Intracerebroventricular drug administration in pigeons.
Pharmacology, biochemistry, and behavior 1985;23(5):731-6.
1985: Charles France; James H Woods
Antagonistic and rate-suppressing effects of opioid antagonists in the pigeon.
The Journal of pharmacology and experimental therapeutics 1985;235(2):442-7.
1985: D E Gmerek; James H Woods
Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies.
The Journal of pharmacology and experimental therapeutics 1985;235(2):296-301.
1985: M D Aceto; L S Harris; James H Woods; J L Katz; Charles B Smith; F Medzihradsky; A E Jacobson; S Shiotani
Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans).
Japanese journal of pharmacology 1985;39(1):7-19.
1985: Wouter Koek; R Head; Elzbieta Holsztynska; James H Woods; Edward Domino; Arthur E Jacobson; M F Rafferty; Kenner C Rice; R A Lessor
Effects of metaphit, a proposed phencyclidine receptor acylator, on catalepsy in pigeons.
The Journal of pharmacology and experimental therapeutics 1985;234(3):648-53.
1985: Charles France; James H Woods
Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
The Journal of pharmacology and experimental therapeutics 1985;234(1):81-9.
1985: Gail Winger; James H Woods
Comparison of fixed-ratio and progressive-ratio schedules of maintenance of stimulant drug-reinforced responding.
Drug and alcohol dependence 1985;15(1-2):123-30.
1985: James H Woods; D E Gmerek
Substitution and primary dependence studies in animals.
Drug and alcohol dependence 1985;14(3-4):233-47.
1985: Charles France; James H Woods
Effects of morphine, naltrexone, and dextrorphan in untreated and morphine-treated pigeons.
Psychopharmacology 1985;85(3):377-82.
1984: Charles B Smith; L Bennett-Kelly; James H Woods
Comparison of "selective" opiate receptor antagonists on the isolated mouse vas deferens.
Neuropeptides 1984;5(1-3):161-4.
1984: Wouter Koek; James H Woods; K C Rice; A E Jacobson; P N Huguenin; T R Burke
Phencyclidine-induced catalepsy in pigeons: specificity and stereoselectivity.
European journal of pharmacology 1984;106(3):635-8.
1984: S Herling; R J Valentino; R E Solomon; James H Woods
Narcotic discrimination in pigeons: antagonism by naltrexone.
European journal of pharmacology 1984;105(1-2):137-42.
1984: Charles France; A E Jacobson; James H Woods
Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine.
The Journal of pharmacology and experimental therapeutics 1984;230(3):652-7.
1984: F Medzihradsky; P J Dahlstrom; James H Woods; S V Fischel; S E Mitsos
Resolution in the receptor binding of putative mu and kappa opiates.
Life sciences 1984;34(22):2129-38.
1984: Alice M Young; K R Stephens; D W Hein; James H Woods
Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids.
The Journal of pharmacology and experimental therapeutics 1984;229(1):118-26.
1984: Charles France; A E Jacobson; James H Woods
Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine.
NIDA research monograph 1984;49():136-42.
1984: James H Woods
Progress report on the stimulant-depressant abuse liability evaluation project.
NIDA research monograph 1984;49():59-62.
1984: James H Woods; Gail Winger; F Medzihradsky; Charles B Smith; J L Katz
Evaluation of new compounds for opioid activity (1983).
NIDA research monograph 1984;49():361-7.
1984: D Gmerek; James H Woods
Effects of b-FNA in drug-naive and morphine-dependent rhesus monkeys.
NIDA research monograph 1984;55():99-105.
1984: James H Woods; Gail Winger; F Medzihradsky; Charles B Smith; D Gmerek; Mario D Aceto; L S Harris; Everette L May; R L Balster; B L Slifer
Evaluation of new compounds for opioid activity in rhesus monkey, rat, and mouse (1984)
NIDA research monograph 1984;55():309-93.
1984: E A Harrison; M F Rafferty; Kenner C Rice; C R Creveling; Gail Winger; James H Woods; Arthur E Jacobson
Evidence for separation of anesthetic activity from prototypic phencyclidine action in drug discrimination by molecular modification of dioxadrol, a phencyclidine-like dissociative anesthetic.
NIDA research monograph 1984;55():90-6.
1983: S Herling; R E Solomon; James H Woods
Discriminative stimulus effects of dextrorphan in pigeons.
The Journal of pharmacology and experimental therapeutics 1983;227(3):723-31.
1983: R J Valentino; J L Katz; F Medzihradsky; James H Woods
Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
Life sciences 1983;32(25):2887-96.
1983: James H Woods; J L Katz; F Medzihradsky; Charles B Smith; Gail Winger
Evaluation of new compounds for opioid activity: 1982 annual report.
NIDA research monograph 1983;43():457-511.
1983: R J Valentino; S Herling; James H Woods
Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons.
The Journal of pharmacology and experimental therapeutics 1983;224(2):307-13.
1983: James H Woods
Some thoughts on the relations between animal and human drug-taking.
Progress in neuro-psychopharmacology & biological psychiatry 1983;7(4-6):577-84.
1983: D E Gmerek; J L Katz; Charles France; James H Woods
Systemic and intracerebroventricular effects of opioid peptides in withdrawn morphine-dependent rhesus monkeys.
Life sciences 1983;33 Suppl 1():361-4.
1983: James H Woods
Experimental abuse liability assessment of benzodiazepines.
Journal of psychoactive drugs 1983;15(1-2):61-5.
1983: James H Woods; Alice M Young; F Medzihradsky; Charles B Smith; M D Aceto; L S Harris; A E Jacobson
Zomepirac: preclinical narcotic abuse liability evaluation.
Arzneimittel-Forschung 1983;33(2):218-22.
1982: R E Solomon; S Herling; Edward Domino; James H Woods
Discriminative stimulus effects of N-substituted analogs of phencyclidine in rhesus monkeys.
Neuropharmacology 1982;21(12):1329-36.
1982: J L Katz; James H Woods; Gail Winger; A E Jacobson
Compounds of novel structure having kappa-agonist behavioral effects in rhesus monkeys.
Life sciences 1982;31(20-21):2375-8.
1982: J L Falk; Charles R Schuster; George E Bigelow; James H Woods
Progress and needs in the experimental analysis of drug and alcohol dependence.
The American psychologist 1982;37(10):1124-7.
1982: R E Solomon; S Herling; James H Woods
Discriminative stimulus effects of monohydroxylated phencyclidine metabolites in Rhesus monkeys.
European journal of pharmacology 1982;82(3-4):233-7.
1982: R Y Hampton; F Medzihradsky; James H Woods; P J Dahlstrom
Stereospecific binding of 3H-phencyclidine in brain membranes.
Life sciences 1982;30(25):2147-54.
1982: A J Bertalmio; S Herling; R Y Hampton; Gail Winger; James H Woods
A procedure for rapid evaluation of the discriminative stimulus effects of drugs.
Journal of pharmacological methods 1982;7(4):289-99.
1982: Alice M Young; James H Woods
Limitations on the antagonistic actions of opioid antagonists.
Federation proceedings 1982;41(7):2333-8.
1982: James H Woods; J L Katz; F Medzihradsky; Charles B Smith; Alice M Young; Gail Winger
1981 annual report: evaluation of new compounds for opioid activity.
NIDA research monograph 1982;41():381-451.
1982: A E Jacobson; H Schmidhammer; F L Hsu; M D Rozwadowska; L Atwell; Arnold Brossi; M D Aceto; L S Harris; J L Katz; James H Woods; F Medzihradsky
Structure-activity relationships of oxygenated morphinans. III. An exploration of the effect of the aromatic oxygen and 6-keto group on antinociceptive activity, receptor affinity, and narcotic antagonism.
NIDA research monograph 1982;41():86-92.
1982: James H Woods; Alice M Young; S Herling
Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys.
Federation proceedings 1982;41(2):221-7.
1982: S Herling; D W Hein; M A Nemeth; R J Valentino; James H Woods
Discriminative stimulus, antagonist, and rate-decreasing effects of cyclorphan: multiple modes of action.
Life sciences 1982;30(4):331-41.
1981: Alice M Young; James H Woods
Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories.
The Journal of pharmacology and experimental therapeutics 1981;218(3):720-7.
1981: Alice M Young; J L Katz; James H Woods
Behavioral effects of levonantradol and nantradol in the rhesus monkey.
Journal of clinical pharmacology 1981;21(8-9 Suppl):348S-360S.
1981: D W Hein; Alice M Young; S Herling; James H Woods
Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey.
The Journal of pharmacology and experimental therapeutics 1981;218(1):7-15.
1981: Alice M Young; S Herling; James H Woods
History of drug exposure as a determinant of drug self-administration.
NIDA research monograph 1981;37():75-88.
1981: James H Woods; Charles R Schuster; C R Hartel
Behavioral effects of thebaine in the rhesus monkey.
Pharmacology, biochemistry, and behavior 1981;14(6):805-9.
1981: R J Valentino; S Herling; James H Woods; F Medzihradsky; H Merz
Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists.
The Journal of pharmacology and experimental therapeutics 1981;217(3):652-9.
1981: S Herling; James H Woods
Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions.
Life sciences 1981;28(14):1571-84.
1981: R J Valentino; Charles B Smith; James H Woods
Physiological and behavioral approaches to the study of the quasi-morphine withdrawal syndrome.
Federation proceedings 1981;40(5):1502-7.
1981: James H Woods; F Medzihradsky; Charles B Smith; Alice M Young; H H Swain
Annual report: evaluation of new compounds for opioid activity (1980).
NIDA research monograph 1981;34():327-66.
1981: Alice M Young; S Herling; Gail Winger; James H Woods
Comparison of discriminative and reinforcing effects of ketamine and related compounds in the rhesus monkey.
NIDA research monograph 1981;34():173-9.
1981: James H Woods; J L Katz; Alice M Young; F Medzihradsky; Charles B Smith
Correlations among certain behavioral, physiological, and biochemical effects of narcotic agonists.
NIDA research monograph 1981;34():43-57.
1981: R J Valentino; S Herling; James H Woods
The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state [proceedings].
Psychopharmacology bulletin 1981;17(1):51-4.
1981: Alice M Young; H H Swain; James H Woods
Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys.
Psychopharmacology 1981;74(4):329-35.
1981: S Herling; E H Coale; D W Hein; Gail Winger; James H Woods
Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeon.
Psychopharmacology 1981;73(3):286-91.
1981: S Herling; James H Woods
Discriminative stimulus effects of etorphine in Rhesus monkeys.
Psychopharmacology 1981;72(3):265-7.
1980: S Herling; James H Woods
Chlorpromazine effects on cocaine-reinforced responding in rhesus monkeys: reciprocal modification of rate-altering effects of the drugs.
The Journal of pharmacology and experimental therapeutics 1980;214(2):354-61.
1980: S Herling; E H Coale; R J Valentino; D W Hein; James H Woods
Narcotic discrimination in pigeons.
The Journal of pharmacology and experimental therapeutics 1980;214(1):139-46.
1980: James H Woods
Narcotic-reinforced responding: a rapid evaluation procedure.
Drug and alcohol dependence 1980;5(3):223-30.
1980: J S Abelson; James H Woods
Effects of apomorphine on elicited and operant pecking in pigeons.
Psychopharmacology 1980;71(3):237-41.
1980: Alice M Young; James H Woods
Behavior maintained by intravenous injection of codeine, cocaine, and etorphine in the rhesus macaque and the pigtail macaque.
Psychopharmacology 1980;70(3):263-71.
1980: David B Moody; Gail Winger; James H Woods; W C Stebbins
Effect of ethanol and of noise on reaction time in the monkey: variation with stimulus level.
Psychopharmacology 1980;69(1):45-51.
1979: R J Valentino; Charles B Smith; James H Woods
An unusual benzazocine elicits acetylcholine release in the isolated guinea pig ileum.
Nature 1979;281(5730):370-2.
1979: S Herling; D A Downs; James H Woods
Cocaine, d-amphetamine, and pentobarbital effects on responding maintained by food or cocaine in rhesus monkeys.
Psychopharmacology 1979;64(3):261-9.
1979: H H Swain; James H Woods; F Medzihradsky; Charles B Smith; C L Fly
Annual report: evaluation of new compounds for opioid activity (1979).
NIDA research monograph 1979;27():356-98.
1979: James H Woods; S Herling; R J Valentino; D W Hein; E H Coale
Narcotic drug discriminations by rhesus monkeys and pigeons.
NIDA research monograph 1979;27():128-34.
1978: P Tepper; James H Woods
Changes in locomotor activity and naloxone-induced jumping in mice produced by WIN 35, 197-2 (ethylketazocine) and morphine.
Psychopharmacology 1978;58(2):125-9.
1978: A J Karoly; Gail Winger; F Ikomi; James H Woods
The reinforcing property of ethanol in the rhesus monkey II. Some variables related to the maintenance of intravenous ethanol-reinforced responding.
Psychopharmacology 1978;58(1):19-25.
1978: R E Tessel; James H Woods
meta Substituted N-ethylamphetamine self injection responding in the rhesus monkey: structure-activity relationships.
The Journal of pharmacology and experimental therapeutics 1978;205(2):274-81.
1977: James H Woods
Alcohol intoxication and withdrawal--IIIb. Studies in alcohol dependence: introduction to the papers on operant conditioning and alcohol intake.
Advances in experimental medicine and biology 1977;85B():421-2.
1976: J M Carney; M E Llewellyn; James H Woods
Variable interval responding maintained by intravenous codeine and ethanol injections in the rhesus monkey.
Pharmacology, biochemistry, and behavior 1976;5(5):577-52.
1976: D A Downs; James H Woods
Morphine, pentazocine and naloxone effects on responding under a multiple schedule of reinforcement in rhesus monkeys and pigeons.
The Journal of pharmacology and experimental therapeutics 1976;196(2):298-306.
1976: M E Llewellyn; C Iglauer; James H Woods
Relative reinforcer magnitude under a nonindependent concurrent schedule of cocaine reinforcement in rhesus monkeys.
Journal of the experimental analysis of behavior 1976;25(1):81-91.
1975: Gail Winger; Maxine L Stitzer; James H Woods
Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action.
The Journal of pharmacology and experimental therapeutics 1975;195(3):505-14.
1975: R E Tessel; James H Woods
Fenfluramine and N-ethyl amphetamine: comparison of the reinforcing and rate-decreasing actions in the rhesus monkey.
Psychopharmacologia 1975;43(3):239-44.
1975: D A Downs; James H Woods
Naloxone as a negative reinforcer in rhesus monkeys: effects of dose, schedule, and narcotic regimen.
Pharmacological reviews 1975;27(3):397-406.
1975: C Iglauer; M E Llewellyn; James H Woods
Concurrent schedules of cocaine injection in rhesus monkeys: dose variations under independent and non-independent variable-interval procedures.
Pharmacological reviews 1975;27(3):367-83.
1975: James H Woods; D A Downs; J Carney
Behavioral functions of narcotic antagonists: response-drug contingencies.
Federation proceedings 1975;34(9):1777-84.
1975: D A Downs; James H Woods
Food- and drug-reinforced responding: effects of DITA and d-amphetamine.
Psychopharmacologia 1975;43(1):13-7.
1975: D A Downs; James H Woods
Fixed-ratio escape and avoidance-escape from naloxone in morphine-dependent monkeys: effects of naloxone dose and morphine pretreatment.
Journal of the experimental analysis of behavior 1975;23(3):415-27.
1975: R E Tessel; James H Woods; R E Counsell; G P Basmadjian
Structure-activity relationships between meta-substituted N-ethylamphetamines and isolated guinea-pig atrial rate.
The Journal of pharmacology and experimental therapeutics 1975;192(2):319-26.
1975: R E Tessel; James H Woods; R E Counsell; M Lu
Structure-activity relationships between meta-substituted N-ethylamphetamines and locomotor activity in mice.
The Journal of pharmacology and experimental therapeutics 1975;192(2):310-8.
1974: D A Downs; James H Woods
Codeine- and cocaine-reinforced responding in rhesus monkeys: effects of dose on response rates under a fixed-ratio schedule.
The Journal of pharmacology and experimental therapeutics 1974;191(1):179-88.
1974: James H Woods; R E Tessel
Fenfluramine: amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey.
Science (New York, N.Y.) 1974;185(4156):1067-9.
1974: C Iglauer; James H Woods
Concurrent performances: reinforcement by different doses of intravenous cocaine in rhesus monkeys.
Journal of the experimental analysis of behavior 1974;22(1):179-96.
1974: James H Woods; Gail Winger
Alcoholism and animals.
Preventive medicine 1974;3(1):49-60.
1973: Gail Winger; James H Woods
The reinforcing property of ethanol in the rhesus monkey. I. Initiation, maintenance and termination of intravenous ethanol-reinforced responding.
Annals of the New York Academy of Sciences 1973;215():162-5.
1971: S R Goldberg; James H Woods; Charles R Schuster
Nalorphine-induced changes in morphine self-administration in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1971;176(2):464-71.
1969: S R Goldberg; James H Woods; Charles R Schuster
Morphine: conditioned increases in self-administration in rhesus monkeys.
Science (New York, N.Y.) 1969;166(3910):1306-7.
1966: Charles R Schuster; James H Woods
Schedule-induced polydipsia in the rhesus monkey.
Psychological reports 1966;19(3):823-8.
1966: Charles R Schuster; W S Dockens; James H Woods
Behavioral variables affecting the development of amphetamine tolerance.
Psychopharmacologia 1966;9(2):170-82.